BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/20/2018 2:33:54 AM | Browse: 1038 | Download: 928
|
Received |
|
2018-06-06 00:55 |
|
Peer-Review Started |
|
2018-06-06 09:10 |
|
To Make the First Decision |
|
2018-07-12 01:26 |
|
Return for Revision |
|
2018-07-12 08:51 |
|
Revised |
|
2018-08-14 21:31 |
|
Second Decision |
|
2018-08-20 08:12 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2018-08-24 09:24 |
|
Articles in Press |
|
2018-08-24 09:24 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-09-17 01:06 |
|
Publish the Manuscript Online |
|
2018-09-20 02:33 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Minireviews |
Article Title |
Biosimilars in paediatric inflammatory bowel disease
|
Manuscript Source |
Invited Manuscript |
All Author List |
Joanna Sieczkowska-Golub, Dorota Jarzebicka, Grzegorz Oracz and Jaroslaw Kierkus |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Jaroslaw Kierkus, MD, PhD, Full Professor, The Department of Gastroenterology, Hepatology, Feeding Disorders and Paediatrics, The Children’s Memorial Health Institute, Aleja Dzieci Polskich 20, Warsaw 04-730, Poland. j.kierkus@med-net.pl |
Key Words |
Biosimilars; Paediatric inflammatory bowel disease; Infliximab; Biological treatment; Crohn’s disease; Ulcerative colitis |
Core Tip |
Data on the use of biosimilars among paediatric patients are limited. Nevertheless, several original papers support adult findings that biosimilars are as effective and safe as the reference infliximab in this population. |
Publish Date |
2018-09-20 02:33 |
Citation |
Sieczkowska-Golub J, Jarzebicka D, Oracz G, Kierkus J. Biosimilars in paediatric inflammatory bowel disease. World J Gastroenterol 2018; 24(35): 4021-4027 |
URL |
http://www.wjgnet.com/1007-9327/full/v24/i35/4021.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v24.i35.4021 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345